Induction Chemotherapy With an Anti-GD2 Monoclonal Antibody (Dinutuximab) and Cytokines in Children With Newly Diagnosed High-risk Neuroblastoma: A Case Series.
J Pediatr Hematol Oncol
; 43(5): e692-e696, 2021 07 01.
Article
em En
| MEDLINE
| ID: mdl-33181583
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Citocinas
/
Anticorpos Monoclonais
/
Neuroblastoma
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article